Mitsubishi Gas Chemical Lifts FY2027 Forecast 30% on Methanol Recovery
Mitsubishi Gas Chemical Company, Inc. (TSE:4182) swung to a net loss of JPY 40.3bn in the fiscal year ended March 2026, despite maintaining operating profitability, as weakness in its flagship methanol joint ventures and one-time charges overwhelmed otherwise resilient core operations. The company projects a sharp earnings rebound next year, with operating profit forecast to surge 30.3% to JPY 59.0bn, signaling management confidence in market recovery—though execution risks remain elevated amid geopolitical uncertainty.
| Metric | FY2026 Actual | FY2027 Forecast | Change |
|---|---|---|---|
| Revenue | JPY 738.2bn | JPY 840.0bn | +13.8% |
| Operating Profit | JPY 45.3bn | JPY 59.0bn | +30.3% |
| Ordinary Income | JPY 51.9bn | JPY 66.0bn | +27.1% |
| Net Profit | JPY −40.3bn | JPY 46.0bn | Return to black |
Business Overview
Mitsubishi Gas Chemical Company, Inc. is a diversified chemical manufacturer with world-leading positions in methanol production through overseas joint ventures, alongside operations in basic chemicals, fine chemicals, and functional materials. The company serves automotive, electronics, pharmaceutical, and industrial end-markets globally, with significant exposure to commodity chemical cycles and emerging-market demand volatility.
FY2026 Results: Profit Deterioration Masks Operational Resilience
Revenue declined a modest 4.6% year-on-year to JPY 738.2bn, but operating profit contracted 10.9% to JPY 45.3bn, with ordinary income (keijo rieki, Japan’s recurring profit metric that includes financial income and losses) falling 13.9% to JPY 51.9bn. This accelerating profit decline signals structural headwinds beyond top-line softness.
The culprit is clear: equity-method investment income from overseas methanol joint ventures collapsed 89.1%, from JPY 11.0bn to JPY 1.5bn. As a world-tier methanol producer, Mitsubishi Gas Chemical’s earnings are acutely sensitive to commodity methanol pricing and global supply-demand dynamics. The sharp deterioration points to oversupply in methanol markets, price compression, and weakened demand in China and Europe—headwinds that flowed directly through to the bottom line.
The net loss of JPY 40.3bn, despite positive operating profit of JPY 45.3bn, indicates material extraordinary losses or non-operating charges not detailed in preliminary disclosures. These likely include impairments on overseas assets, foreign exchange losses, or other one-time items typical of cyclical downturns in commodity chemical operations.
Operating margin compressed to 6.1%, reflecting the earnings pressure. The equity ratio edged down to 58.1% from 59.7%, a modest deterioration that underscores the company’s reliance on retained earnings to absorb cyclical losses.
Next Year Guidance
Management projects a forceful earnings recovery in FY2027, with revenue rising 13.8% to JPY 840.0bn and operating profit surging 30.3% to JPY 59.0bn. Ordinary income is forecast at JPY 66.0bn (+27.1%), with net profit returning to black at JPY 46.0bn. These targets are ambitious, implying a sharp rebound in methanol joint-venture profitability and assume meaningful improvement in global commodity chemical demand. The 30%-plus operating profit growth assumes methanol market stabilization and recovery in Asian demand—outcomes far from assured in the current macro environment.
Notably, the company increased its dividend to JPY 100.00/share for FY2026 (from JPY 95.00) despite the net loss, and plans JPY 110.00/share for FY2027. This progressive dividend policy signals management’s conviction in the recovery thesis, though it also reflects a commitment to shareholder returns independent of near-term earnings volatility.
What to Watch
Methanol Market Dynamics: The equity-method loss swing from JPY 11.0bn to JPY 1.5bn is the critical variable. Investors should monitor global methanol supply-demand balances, Chinese industrial production data, and European chemical sector activity. Any sustained weakness in these indicators would undermine the FY2027 guidance.
US Trade Policy and Currency: Management cited uncertainty from US tariff policy as a headwind. Yen weakness could support export competitiveness, but tariff escalation targeting chemical imports or retaliatory measures against Japanese exporters could derail the recovery narrative.
Execution on One-Time Items: Clarification on the nature and magnitude of FY2026 extraordinary losses will be critical when the full annual report is filed. If impairments signal structural asset value destruction rather than temporary cyclical losses, the recovery outlook may require downward revision.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Financial figures are AI-extracted and may contain errors — always verify against the original filing.